Liabilities / Assets
68th percentile
Higher debt load relative to assets than 68% of similar nonprofits.
EIN 73-1386920 • 501(c)3 • Schaumburg, IL
Profile
To fund innovative and life-changing clinical studies that accelerate new treatment options for cancer patients.
Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.
Liabilities / Assets
68th percentile
Higher debt load relative to assets than 68% of similar nonprofits.
Liabilities / Revenue
78th percentile
Higher debt load relative to revenue than 78% of similar nonprofits.
Net Margin
58th percentile
Higher net margin than 58% of similar nonprofits.
Top Officer Pay
76th percentile
Higher top officer pay than 76% of similar nonprofits.
Top officer pay equals 3.1% of source-year revenue.
Asset Growth
49th percentile
Faster asset growth than 49% of similar nonprofits.
Revenue Growth
19th percentile
Faster revenue growth than 19% of similar nonprofits.
Assets
Up$20,261,940
Up $2,676,384 (+15%) from 2022
Liabilities
Down$10,138,659
Down $2,281,663 (-18%) from 2022
Net Assets
Up$10,123,281
Up $4,958,047 (+96%) from 2022
Revenue
Up$10,470,741
Up $1,693,487 (+19%) from 2022
Expenses
Up$9,525,588
Up $876,482 (+10%) from 2022
Net Income
Up$945,153
Up $817,005 (+638%) from 2022
Most recent year
2023 • Form 990Summary only. Only limited summary data is available for this year.